Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

LIMPRINT in Specialist Lymphedema Services in United Kingdom, France, Italy, and Turkey

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Keeley, V, Franks, P, Quere, I, Mercier, G, Michelini, S, Cestari, M, Borman, P, Hughes, A, Clark, K, Lisle, J, Benson, M, Noerregaard, S, Karlsmark, T, Murray, S & Moffatt, C 2019, 'LIMPRINT in Specialist Lymphedema Services in United Kingdom, France, Italy, and Turkey' Lymphatic Research and Biology, vol. 17, no. 2, pp. 141-146. https://doi.org/10.1089/lrb.2019.0021

APA

CBE

Keeley V, Franks P, Quere I, Mercier G, Michelini S, Cestari M, Borman P, Hughes A, Clark K, Lisle J, Benson M, Noerregaard S, Karlsmark T, Murray S, Moffatt C. 2019. LIMPRINT in Specialist Lymphedema Services in United Kingdom, France, Italy, and Turkey. Lymphatic Research and Biology. 17(2):141-146. https://doi.org/10.1089/lrb.2019.0021

MLA

Vancouver

Author

Keeley, Vaughan ; Franks, Peter ; Quere, Isabelle ; Mercier, Gregoire ; Michelini, Sandro ; Cestari, Marina ; Borman, Pinar ; Hughes, Andrew ; Clark, Kath ; Lisle, Jill ; Benson, Margaret ; Noerregaard, Susan ; Karlsmark, Tonny ; Murray, Susie ; Moffatt, Christine. / LIMPRINT in Specialist Lymphedema Services in United Kingdom, France, Italy, and Turkey. In: Lymphatic Research and Biology. 2019 ; Vol. 17, No. 2. pp. 141-146.

Bibtex

@article{70ae2a069a0a40c8bd35f910dbe6dc23,
title = "LIMPRINT in Specialist Lymphedema Services in United Kingdom, France, Italy, and Turkey",
abstract = "Background: There is no standardized international model for specialist lymphedema services, which covers the types of lymphedema treated and the treatments provided. The aim of this study was to provide a profile of patients attending specialist lymphedema services in different countries to explore similarities and differences. Methods and Results: The LIMPRINT core tool was used in specialist lymphedema services in the United Kingdom, France, Italy, and Turkey. Services in Turkey saw a slightly younger age group, with a higher proportion of female patients reflecting a particular focus on breast cancer-related lymphedema. There were higher levels of obesity and restricted mobility in patients in the United Kingdom compared with other countries. Italy and France saw the highest percentage of patients with primary lymphedema. Diabetes was a common comorbidity in the United Kingdom and Turkey. The United Kingdom saw the largest number of patients with lower limb lymphedema. Conclusions: The results show a wide range of complexity of patients treated in specialist lymphedema services. Some of the differences between countries may reflect different stages in the evolution of specialist lymphedema services, rather than a true difference in prevalence, with those with {"}younger{"} services treating a high proportion of patients with cancer and those with more established services treating a wider range of different types of lymphedema, including more elderly people with multiple comorbidities.",
keywords = "Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Breast Neoplasms/diagnosis, Cellulitis/diagnosis, Child, Child, Preschool, Chronic Disease, Diabetes Mellitus/diagnosis, Diagnosis, Differential, Edema/diagnosis, Female, France/epidemiology, Humans, Italy/epidemiology, Lower Extremity/pathology, Lymphatic System/pathology, Lymphedema/diagnosis, Male, Middle Aged, Neurocognitive Disorders/diagnosis, Obesity, Morbid/diagnosis, Practice Guidelines as Topic, Prevalence, Risk Factors, Turkey/epidemiology, United Kingdom/epidemiology",
author = "Vaughan Keeley and Peter Franks and Isabelle Quere and Gregoire Mercier and Sandro Michelini and Marina Cestari and Pinar Borman and Andrew Hughes and Kath Clark and Jill Lisle and Margaret Benson and Susan Noerregaard and Tonny Karlsmark and Susie Murray and Christine Moffatt",
year = "2019",
month = "4",
doi = "10.1089/lrb.2019.0021",
language = "English",
volume = "17",
pages = "141--146",
journal = "Lymphatic Research and Biology",
issn = "1539-6851",
publisher = "Mary AnnLiebert, Inc. Publishers",
number = "2",

}

RIS

TY - JOUR

T1 - LIMPRINT in Specialist Lymphedema Services in United Kingdom, France, Italy, and Turkey

AU - Keeley, Vaughan

AU - Franks, Peter

AU - Quere, Isabelle

AU - Mercier, Gregoire

AU - Michelini, Sandro

AU - Cestari, Marina

AU - Borman, Pinar

AU - Hughes, Andrew

AU - Clark, Kath

AU - Lisle, Jill

AU - Benson, Margaret

AU - Noerregaard, Susan

AU - Karlsmark, Tonny

AU - Murray, Susie

AU - Moffatt, Christine

PY - 2019/4

Y1 - 2019/4

N2 - Background: There is no standardized international model for specialist lymphedema services, which covers the types of lymphedema treated and the treatments provided. The aim of this study was to provide a profile of patients attending specialist lymphedema services in different countries to explore similarities and differences. Methods and Results: The LIMPRINT core tool was used in specialist lymphedema services in the United Kingdom, France, Italy, and Turkey. Services in Turkey saw a slightly younger age group, with a higher proportion of female patients reflecting a particular focus on breast cancer-related lymphedema. There were higher levels of obesity and restricted mobility in patients in the United Kingdom compared with other countries. Italy and France saw the highest percentage of patients with primary lymphedema. Diabetes was a common comorbidity in the United Kingdom and Turkey. The United Kingdom saw the largest number of patients with lower limb lymphedema. Conclusions: The results show a wide range of complexity of patients treated in specialist lymphedema services. Some of the differences between countries may reflect different stages in the evolution of specialist lymphedema services, rather than a true difference in prevalence, with those with "younger" services treating a high proportion of patients with cancer and those with more established services treating a wider range of different types of lymphedema, including more elderly people with multiple comorbidities.

AB - Background: There is no standardized international model for specialist lymphedema services, which covers the types of lymphedema treated and the treatments provided. The aim of this study was to provide a profile of patients attending specialist lymphedema services in different countries to explore similarities and differences. Methods and Results: The LIMPRINT core tool was used in specialist lymphedema services in the United Kingdom, France, Italy, and Turkey. Services in Turkey saw a slightly younger age group, with a higher proportion of female patients reflecting a particular focus on breast cancer-related lymphedema. There were higher levels of obesity and restricted mobility in patients in the United Kingdom compared with other countries. Italy and France saw the highest percentage of patients with primary lymphedema. Diabetes was a common comorbidity in the United Kingdom and Turkey. The United Kingdom saw the largest number of patients with lower limb lymphedema. Conclusions: The results show a wide range of complexity of patients treated in specialist lymphedema services. Some of the differences between countries may reflect different stages in the evolution of specialist lymphedema services, rather than a true difference in prevalence, with those with "younger" services treating a high proportion of patients with cancer and those with more established services treating a wider range of different types of lymphedema, including more elderly people with multiple comorbidities.

KW - Adolescent

KW - Adult

KW - Age Factors

KW - Aged

KW - Aged, 80 and over

KW - Breast Neoplasms/diagnosis

KW - Cellulitis/diagnosis

KW - Child

KW - Child, Preschool

KW - Chronic Disease

KW - Diabetes Mellitus/diagnosis

KW - Diagnosis, Differential

KW - Edema/diagnosis

KW - Female

KW - France/epidemiology

KW - Humans

KW - Italy/epidemiology

KW - Lower Extremity/pathology

KW - Lymphatic System/pathology

KW - Lymphedema/diagnosis

KW - Male

KW - Middle Aged

KW - Neurocognitive Disorders/diagnosis

KW - Obesity, Morbid/diagnosis

KW - Practice Guidelines as Topic

KW - Prevalence

KW - Risk Factors

KW - Turkey/epidemiology

KW - United Kingdom/epidemiology

U2 - 10.1089/lrb.2019.0021

DO - 10.1089/lrb.2019.0021

M3 - Journal article

VL - 17

SP - 141

EP - 146

JO - Lymphatic Research and Biology

JF - Lymphatic Research and Biology

SN - 1539-6851

IS - 2

ER -

ID: 59134023